Racial Differences in Women Who have a Hysterectomy for Benign Conditions

Women's Health Issues

Volumn 19, Issue 3, 2009, Pages 202-210

  Weiss, Gerson ^a   Noorhasan, Dorette ^a   Schott, Laura L ^b   Powell, Lynda ^c   Randolph Jr , John F ^d   Johnston, Janet M ^e  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e Alaska Native Epidemiology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; TESTOSTERONE;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CAUCASIAN; CHRONIC PAIN; COHORT ANALYSIS; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; PARITY; PHYSICAL ACTIVITY; QUALITY OF LIFE; RACE DIFFERENCE; SELF CONCEPT; STATISTICAL ANALYSIS; TESTOSTERONE BLOOD LEVEL; UTERUS MYOMA; UTERUS PROLAPSE; UTERUS WEIGHT; VAGINA BLEEDING; WAIST HIP RATIO;

AFRICAN AMERICANS; COHORT STUDIES; ESTRADIOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYSTERECTOMY; LEIOMYOMA; LOGISTIC MODELS; LONGITUDINAL STUDIES; MIDDLE AGED; ORGAN SIZE; PAIN; TESTOSTERONE; UTERINE NEOPLASMS; UTERINE PROLAPSE; UTERUS;

EID: 65549170526     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.whi.2009.03.001     Document Type: Article

References (33)

1. Al-Hendy A., and Salama S.A. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. Journal of the Society for Gynecologic Investigation 13 (2006) 136-144
2. Al-Hendy A., and Salama S.A. Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertility & Sterility 86 (2006) 686-693
3. Baird D.D., Dunson D.B., Hill M.C., Cousins D., and Schectman J.M. Association of physical activity with development of uterine leiomyoma. American Journal of Epidemiology 165 (2007) 157-163
4. Brett K.M., Marsh J.V., and Madans J.H. Epidemiology of hysterectomy in the United States: demographic and reproductive factors in a nationally representative sample. Journal of Womens Health 6 (1997) 309-316
5. Bump R.C. Racial comparisons and contrasts in urinary incontinence and pelvic organ prolapse. Obstetrics and Gynecology 81 (1993) 421-425
6. Chiaffarino F., Parazzini F., La Vecchia C., Chatenoud L., Di Cintio E., and Marsico S. Diet and uterine myomas. Obstetrics and Gynecology 94 (1999) 395-398
7. Day Baird D., Dunson D.B., Hill M.C., Cousins D., and Schectman J.M. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. American Journal of Obstetrics and Gynecology 188 (2003) 100-107
8. England B.G., Parsons G.H., Possley R.M., McConnell D.S., and Midgley A.R. Ultrasensitive semiautomated chemiluminescent immunoassay for estradiol. Clinical Chemistry 48 (2002) 1584-1586
9. Faerstein E., Szklo M., and Rosenshein N. Risk factors for uterine leiomyoma: A practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. American Journal of Epidemiology 153 (2001) 1-10
10. Folkerd E.J., Newton C.J., Davidson K., Anderson M.C., and James V.H. Aromatase activity in uterine leiomyomata. Journal of Steroid Biochemistry 20 (1984) 1195-1200
11. Hillis S.D., Marchbanks P.A., and Peterson H.B. Uterine size and risk of complications among women undergoing abdominal hysterectomy for leiomyomas. Obstetrics and Gynecology 87 (1996) 539-543
12. Hosmer D.W., and Lemeshow S. Applied logistic regression (1989), John Wiley & Sons, Inc, New York
13. Howard D., Delancey J.O., Tunn R., and Ashton-Miller J.A. Racial differences in the structure and function of the stress urinary continence mechanism. Obstetrics and Gynecology 95 (2000) 713-717
14. Huyck K.L., Panhuysen C.I., Cuenco K.T., Zhang J., Goldhammer H., Jones E.S., et al. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. American Journal of Obstetrics and Gynecology 198 (2008) 168 e161-169
15. Keshavarz H., Kieke B., and Marchbanks P. Hysterectomy surveillance-United States 1994-1999. Morbidity and Mortality Weekly Report Surveillance Summaries 51 (2002) 1-8
16. Kjerulff K.H., Guzinski G.M., Langenberg P.W., Stolley P.D., Moye N.E., and Kazandjian V.A. Hysterectomy and race. Obstetrics and Gynecology 82 (1993) 757-764
17. Kjerulff K.H., Langenberg P., Seidman J.D., Stolley P.D., and Guzinski G.M. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. Journal of Reproductive Medicine 41 (1996) 483-490
18. Marshall L.M., Spiegelman D., Barbieri R.L., Goldman M.B., Manson J.E., Colditz G.A., et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstetrics and Gynecology 90 (1997) 967-973
19. Powell L.H., Meyer P., Weiss G., Matthews K.A., Santoro N., Randolph Jr. J.F., et al. Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues 15 (2005) 179-186
20. Reddy V.V., and Rose L.I. delta 4-3-Ketosteroid 5 alpha-oxidoreductase in human uterine leiomyoma. American Journal of Obstetrics and Gynecology 135 (1979) 415-418
21. Rortveit G., Brown J.S., Thom D.H., Van Den Eeden S.K., Creasman J.M., and Subak L.L. Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstetrics and Gynecology 109 (2007) 1396-1403
22. Ross R.K., Pike M.C., Vessey M.P., Bull D., Yeates D., and Casagrande J.T. Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives. British Medical Journal (Clinical Research Edition) 293 (1986) 359-362
23. Sowers M.F., Beebe J.L., McConnell D., Randolph J., and Jannausch M. Testosterone concentrations in women aged 25-50 years: Associations with lifestyle, body composition, and ovarian status. American Journal of Epidemiology 153 (2001) 256-264
24. Sowers M.F., Crawford S.L., and Sternfeld B. SWAN: A multicenter, multiethnic, community-based cohort study of women and the menopausal transition. Lobo, Kelsey, Marcus. Menopause: Biology and Pathobiology (2000), Academic Press, San Diego
25. Spies J.B., Coyne K., Guaou Guaou N., Boyle D., Skyrnarz-Murphy K., and Gonzalves S.M. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstetrics and Gynecology 99 (2002) 290-300
26. Sternfeld B., Ainsworth B.E., and Quesenberry C.P. Physical activity patterns in a diverse population of women. Preventive Medicine 28 (1999) 313-323
27. Terry K.L., De Vivo I., Hankinson S.E., Spiegelman D., Wise L.A., and Missmer S.A. Anthropometric characteristics and risk of uterine leiomyoma. Epidemiology 18 (2007) 758-763
28. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 30 (1992) 473-483
29. Wilcox L.S., Koonin L.M., Pokras R., Strauss L.T., Xia Z., and Peterson H.B. Hysterectomy in the United States, 1988-1990. Obstetrics and Gynecology 83 (1994) 549-555
30. Williams V.S., Jones G., Mauskopf J., Spalding J., and DuChane J. Uterine fibroids: A review of health-related quality of life assessment. Journal of Womens Health (Larchmont) 15 (2006) 818-829
31. Wise L.A., Palmer J.R., Spiegelman D., Harlow B.L., Stewart E.A., Adams-Campbell L.L., et al. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology 16 (2005) 346-354
32. Wise L.A., Palmer J.R., Stewart E.A., and Rosenberg L. Polycystic ovary syndrome and risk of uterine leiomyomata. Fertility & Sterility 87 (2007) 1108-1115
33. Yamamoto T., Takamori K., and Okada H. Estrogen biosynthesis in leiomyoma and myometrium of the uterus. Hormone and Metabolic Research 16 (1984) 678-679